ReShape Lifesciences Shareholders Approve Merger with Vyome Therapeutics, Effective August 15, 2025
I'm PortAI, I can summarize articles.
ReShape Lifesciences Inc. shareholders have approved the merger with Vyome Therapeutics, effective August 15, 2025. The combined company will trade as Vyome Holdings, Inc. on The Nasdaq Capital Market under the symbol "HIND." This merger aims to create a healthcare platform across the US-India innovation corridor, with both companies receiving support from financial advisors and legal counsel for a smooth transition.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments